Sign In
Buy R
$260.38
+2.32 (+0.90%)
At Close: Jun 03, 2026
Ryder System: Strong Fundamentals Justify Its Premium Valuation
11:28am, Thursday, 23'rd Apr 2026
Ryder System has improved business resilience via a shift to leasing and conservative depreciation, supporting higher quality earnings and a 65% stock rally over the past year. Q1 results showed $2.54
Ryder (R) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Thursday, 23'rd Apr 2026
While the top- and bottom-line numbers for Ryder (R) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wal
Ryder (R) Tops Q1 Earnings Estimates
09:10am, Thursday, 23'rd Apr 2026
Ryder (R) came out with quarterly earnings of $2.54 per share, beating the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $2.46 per share a year ago.
Ryder Reports First Quarter 2026 Results
06:55am, Thursday, 23'rd Apr 2026
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder System, Inc. (NYSE: R) reported results for the three months ended March 31 as follows: Earnings Before Taxes Earnings Diluted Earnings Per
SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brai
BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting
10:25am, Tuesday, 21'st Apr 2026
BioInvent International (STO:BINV) - BI-1808 multiplies by three the overall response rate as compared to pembrolizumab alone, supporting its potential to enhance antitumoral immune responses when com
Unveiling Ryder (R) Q1 Outlook: Wall Street Estimates for Key Metrics
10:16am, Tuesday, 21'st Apr 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Ryder (R), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter
Ryder Returns to ACT Expo 2026 to Spotlight Advanced Vehicle Technology Solutions & Industry Expertise
06:55am, Tuesday, 21'st Apr 2026
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder System, Inc. (NYSE: R) will return to the Advanced Clean Transportation (ACT) Expo, May 4–7 in Las Vegas, showcasing the company's industry expertise
GMG's Graphene Engine Oil Additive G(R) LUBRICANT: Patent Granted in USA; Allowed in China
07:40am, Monday, 20'th Apr 2026
Brisbane, Queensland, Australia--(Newsfile Corp. - April 20, 2026) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to advise that GMG's patent for GMG
Ryder (R) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:00am, Thursday, 16'th Apr 2026
Ryder (R) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Collaboration with leading European orthopedic center in Italy supports GelrinC® clinical adoption Renowned cartilage regeneration expert Prof. Elizaveta Kon to help lead Regentis Centers of Excellen
Ryder Expands Alabama Footprint With New Truck Rental and Maintenance Facility in Huntsville
06:55am, Thursday, 16'th Apr 2026
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) is expanding its Southeast presence with the opening of a new 10,000-square‑foot full-service commercial truck rental and maintenance facility in
Ryder System Inc (R) Stock Down 3.5% but Still Overvalued -- GF Score: 85/100
06:22pm, Wednesday, 15'th Apr 2026
On April 15, 2026, Ryder System Inc (R) shares fell 3.5% to a price of $212.05. This move comes within a 52-week price range of $130.16 to $230.39, highlighting
Ryder Named to Fortune's “America's Most Innovative Companies” List for Second Consecutive Year
06:55am, Tuesday, 14'th Apr 2026
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) has been named to Fortune's “America's Most Innovative Companies” list for the second year in a row, underscoring the company's expanding role
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
07:00am, Monday, 13'th Apr 2026
Toronto, Ontario--(Newsfile Corp. - April 13, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to
